AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. (ANTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ANTX · as of Jun 8, 2026
Key Statistics
Explore AN2 Therapeutics, Inc. Data
antx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 62.5%
The ANTX analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $9.00, representing +133.77% upside from the current price of $3.85.
Competitors & Peers
antx competitorsANTX
BOLD
IBIO
INTS
ITRM
NXTCStock Performance
Full HistoryAbout AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of treatments for uncommon, long-term, and severe infectious conditions.…
what is an2 therapeutics, inc. · antx stock overview · an2 therapeutics, inc. company profile · who is an2 therapeutics, inc. ceo · antx NASDAQ · an2 therapeutics, inc. headquarters · an2 therapeutics, inc. business segments
About Stock Overview & Key Data
AN2 Therapeutics, Inc. (ANTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 25, 2022. As of the latest trading session, ANTX stock price is $3.85, with a market capitalization of $105.5M. The stock has returned +243.75% over the past 12 months and +237.72% year-to-date.
According to 8 Wall Street analysts, the consensus rating for AN2 Therapeutics, Inc. stock is Buy, with an average 12-month price target of $9.00. In fiscal year 2025, AN2 Therapeutics, Inc. reported revenue of — and net income of -$35.2M. For detailed data — including AN2 Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, AN2 Therapeutics, Inc. (ANTX) stock price is $3.85. The stock is traded on NASDAQ under the ticker symbol ANTX. The 52-week range is $1.00 – $6.91.